State Street’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$144K Buy
33,295
+3,800
+13% +$16.4K ﹤0.01% 3902
2025
Q1
$110K Sell
29,495
-6
-0% -$22 ﹤0.01% 3953
2024
Q4
$299K Buy
29,501
+2,200
+8% +$22.3K ﹤0.01% 3756
2024
Q3
$340K Sell
27,301
-2,953
-10% -$36.8K ﹤0.01% 3674
2024
Q2
$394K Sell
30,254
-122,132
-80% -$1.59M ﹤0.01% 3612
2024
Q1
$3.45M Buy
152,386
+15,468
+11% +$350K ﹤0.01% 3084
2023
Q4
$1.78M Buy
136,918
+718
+0.5% +$9.32K ﹤0.01% 3350
2023
Q3
$2.74M Sell
136,200
-11,291
-8% -$227K ﹤0.01% 3193
2023
Q2
$3.96M Sell
147,491
-530,908
-78% -$14.3M ﹤0.01% 3110
2023
Q1
$39.6M Buy
678,399
+125,930
+23% +$7.35M ﹤0.01% 1803
2022
Q4
$28.2M Sell
552,469
-48,220
-8% -$2.46M ﹤0.01% 2005
2022
Q3
$49.2M Sell
600,689
-90,112
-13% -$7.38M ﹤0.01% 1607
2022
Q2
$46.7M Sell
690,801
-40,312
-6% -$2.73M ﹤0.01% 1692
2022
Q1
$80.8M Buy
731,113
+363,534
+99% +$40.2M ﹤0.01% 1436
2021
Q4
$35.5M Sell
367,579
-167,088
-31% -$16.1M ﹤0.01% 2064
2021
Q3
$46.7M Buy
534,667
+146,897
+38% +$12.8M ﹤0.01% 1861
2021
Q2
$60M Buy
387,770
+32,285
+9% +$5M ﹤0.01% 1708
2021
Q1
$56.1M Sell
355,485
-506
-0.1% -$79.8K ﹤0.01% 1656
2020
Q4
$82.7M Buy
355,991
+36,726
+12% +$8.53M 0.01% 1293
2020
Q3
$69.9M Buy
319,265
+12,669
+4% +$2.77M ﹤0.01% 1208
2020
Q2
$87.1M Buy
306,596
+90,097
+42% +$25.6M 0.01% 1060
2020
Q1
$62.4M Buy
216,499
+1,275
+0.6% +$367K 0.01% 1105
2019
Q4
$61.9M Buy
215,224
+5,323
+3% +$1.53M ﹤0.01% 1370
2019
Q3
$30.3M Buy
209,901
+135,253
+181% +$19.5M ﹤0.01% 1783
2019
Q2
$6.71M Buy
74,648
+10,403
+16% +$935K ﹤0.01% 2676
2019
Q1
$5.63M Sell
64,245
-103,980
-62% -$9.11M ﹤0.01% 2692
2018
Q4
$23.6M Buy
168,225
+38,845
+30% +$5.46M ﹤0.01% 1866
2018
Q3
$33.1M Sell
129,380
-26,467
-17% -$6.76M ﹤0.01% 1825
2018
Q2
$39.7M Buy
155,847
+89,918
+136% +$22.9M ﹤0.01% 1637
2018
Q1
$13.3M Buy
65,929
+26,610
+68% +$5.36M ﹤0.01% 2327
2017
Q4
$5.66M Buy
39,319
+2,223
+6% +$320K ﹤0.01% 2731
2017
Q3
$6.11M Buy
37,096
+2,968
+9% +$489K ﹤0.01% 2693
2017
Q2
$4.63M Buy
34,128
+3,142
+10% +$426K ﹤0.01% 2775
2017
Q1
$5.97M Buy
30,986
+3,912
+14% +$753K ﹤0.01% 2617
2016
Q4
$3.82M Buy
27,074
+1,668
+7% +$235K ﹤0.01% 2831
2016
Q3
$3.71M Buy
25,406
+648
+3% +$94.6K ﹤0.01% 2729
2016
Q2
$2.49M Buy
24,758
+695
+3% +$69.9K ﹤0.01% 2940
2016
Q1
$3.22M Buy
24,063
+1,319
+6% +$177K ﹤0.01% 2783
2015
Q4
$4.52M Buy
22,744
+2,342
+11% +$466K ﹤0.01% 2586
2015
Q3
$3.22M Sell
20,402
-61,880
-75% -$9.77M ﹤0.01% 2758
2015
Q2
$33.6M Buy
82,282
+16,464
+25% +$6.72M ﹤0.01% 1511
2015
Q1
$30.2M Buy
65,818
+20,908
+47% +$9.6M ﹤0.01% 1545
2014
Q4
$25.2M Buy
44,910
+7,163
+19% +$4.02M ﹤0.01% 1640
2014
Q3
$19.8M Buy
37,747
+26,482
+235% +$13.9M ﹤0.01% 1760
2014
Q2
$7.87M Buy
11,265
+4,017
+55% +$2.8M ﹤0.01% 2347
2014
Q1
$3.36M Sell
7,248
-40
-0.5% -$18.5K ﹤0.01% 2797
2013
Q4
$2.51M Buy
+7,288
New +$2.51M ﹤0.01% 2961